Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Eye Drops in Chronic Central Serous Chorioretinopathy (PICS)
NCT05633576Phase 3Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2023
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Chronic central serous chorioretinopathy (CSCR) comparing steroid eye drops with Placebo (2 arms). Primary endpoint: Change in sub- and intraretinal fluid on OCT scan at 1 month. Started Feb 2023; status: recruiting.
02
Drugs
Steroid eye drops
03
Conditions
Chronic central serous chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT05633576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05633576.